Interstitial Lung Disease Algorithm Defined in "Interstitial Lung Disease (ILD) in Patients with Inflammatory Bowel Disease (IBD) and Following Vedolizumab or Natalizumab Initiation: A Descriptive Analysis"

This report lists International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes and algorithms used to define interstitial lung disease (ILD) in this request.

For additional information about the algorithm and how it was defined relative to the cohort and exposures of interest in the analysis, refer to the analysis webpage here.